Myricitrin may play role in preventing neuronal degeneration in Parkinson's disease

NewsGuard 100/100 Score

A new study has shown that myricitrin, a flavinoid with antioxidant and anti-inflammatory activity that is present inedible plants and fruit, can protect mouse brains from the loss of dopamine-producing neurons caused by neurotoxicity. The reported effects of myricitrin suggest that it could have a role in preventing the neuronal degeneration that occurs in Parkinson's disease, as described in an article published in Journal of Medicinal Food, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Medicinal Food website until July 6, 2016.

Heung Deok Kim, Kyoung Hoon Jeong, Un Ju Jung and San Ryong Kim, Kyungpook National University (Daegu) and Pukyong National University (Busan), Korea, demonstrated the ability of myricitrin to help maintain two key functions of mouse neurons exposed to a neurotoxic agent: the enzymatic activity of tyrosine hydroxylase and rapamycin complex 1 activation. The authors present their findings in the article entitled "Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Landmark study confirms five key Parkinson's Disease variants in largest meta-analysis